epcoritamab
abbvie,genmab
['epcoritamab', '$gmab', '$abbv', 'abbvie']
$abbv $gmab abbvie announces late breaking phase 2 trial results of investigational epcoritamab in relapsed/refractory lbcl patents at eha 2022 congress 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities